Does Delta Hemoglobin-Albumin-Lymphocyte Platelet (HALP) Score Predict the Risk of Early Progression in Patients Treated with CDK4/6 Inhibitors?

Aim: This study aims to determine the predictive value of dynamic change in hemoglobin-albumin-lymphocyte-platelet (HALP) score on treatment response in hormone-positive metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors. Materials and Methods: This study was d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Burcu Belen GÜLBAĞCI, Miraç ÖZEN, Esra ÖZEN ENGİN, Fatma AKDAĞ KAHVECİOĞLU, Esra ÇİFTÇİ, İlhan HACIBEKİROĞLU
Format: Artigo
Idioma:Inglês
Publicat: Tekirdağ Namık Kemal University 2024-12-01
Col·lecció:Namık Kemal Tıp Dergisi
Matèries:
cyclin-dependent kinase (cdk) 4/6 inhibitors
delta halp score
hemoglobin-albumin-lymphocyte-platelet (halp) score
Accés en línia:https://namikkemalmedj.com/articles/does-delta-hemoglobin-albumin-lymphocyte-platelet-halp-score-predict-the-risk-of-early-progression-in-patients-treated-with-cdk46-inhibitors/doi/nkmj.galenos.2024.12599
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars